For CVD Patients, Calcium Supplements May Spur Recurrent Events

Why It Matters

Calcium supplementation alone may exacerbate cardiovascular risk in patients with prior events, prompting clinicians to revise prescribing practices and emphasize combined vitamin D therapy or diet‑based calcium intake.

Key Takeaways

• Calcium-only supplements raise recurrent CVD risk by ~10% overall
• Risk climbs to 58% with doses ≥1,000 mg daily
• Adding vitamin D neutralizes the cardiovascular risk
• Men experience slightly higher risk increase than women

Pulse Analysis

The new Hong Kong analysis adds weight to a growing body of evidence that calcium pills, long touted for bone health, can be a double‑edged sword for patients with existing cardiovascular disease. By leveraging electronic health records for over 237,000 adults and applying propensity‑score matching, researchers isolated the effect of calcium supplementation from confounding comorbidities. The findings echo earlier population studies but are the first to focus exclusively on a high‑risk CVD cohort, revealing a modest yet consistent 10% uptick in composite events and a striking 58% surge among those consuming at least 1,000 mg daily. Notably, the hazard disappears when vitamin D accompanies calcium, underscoring a potential protective synergy.

Clinicians should interpret these results as a call to reassess supplement regimens for post‑event patients. The inexpensive, low‑risk addition of vitamin D appears to offset the calcium‑induced calcium spikes that may promote arterial calcification and hypercoagulability. For patients reluctant or unable to take vitamin D, encouraging sunlight exposure or shifting toward calcium‑rich foods—leafy greens, beans, and fish—offers a pragmatic alternative. This nuanced approach aligns with broader preventive cardiology strategies that prioritize modifiable risk factors while preserving bone health.

From a policy perspective, the study highlights the need for clearer labeling and guidance on over‑the‑counter calcium products, especially given the observed higher risk among non‑prescribed users. Future research may explore the gut microbiome’s role in mediating these effects, as hinted by the investigators. Until then, a balanced calcium intake—meeting, not exceeding, the 1,200 mg daily recommendation—combined with adequate vitamin D, represents the safest path for patients navigating the intersecting demands of cardiovascular and skeletal health.